Introduction :
Intradetrusor injections of botulinum toxin type A (IDBTX-A) : gold standard in adults for treatment of neurogenic detrusor over activity resistant to anticholinergics. Objective : assess the effectiveness of IDBTX-A in children with spina bifida Results :
• 53 patients, mean age of 8.5 years • 133 IDBTX-A • 33 patients (62%) had a second injection • median interval between the first two injections was 9 months.
• Patients with low compliance bladder without detrusor overactivity had no urodynamic improvement
PRIMARY ENDPOINT : Clinical and urodynamic success GLOBAL SUCESS RATE = 30%

GENDER TYPE OF SPINAL DYSRAPHISM TYPE OF URODYNAMIC DISORDERS
No difference p=0,12 Closed (48%) > Open (9%) p = 0,002 No difference p = 0,96
Clinical results
Gender
Type of spinal dysraphism
Type of urodynamic disorders
No difference (p = 0,76)
No difference (p = 0,91)
No difference (p = 0,54) 
